UTILIZACIÓN DE ESTÁNDARES EN EL APRENDIZAJE VIRTUAL FUNCIONALIDADES DIDÁCTICAS DE LA
6. APLICACIONES CONCRETAS DE IMS LD EN EL APRENDIZAJE VIRTUAL
6.6. F ORMAS ALTERNATIVAS DE EVALUACIÓN La evaluación tradicional se basa en la con-
in patients with cn0 squamous cell carcinoma of the oral cavity, the occult metastatic rate was 22% (50 out of the 224 patients) after a combination of palpation and US +/- ultrasound guided FNAC had been used to stage the neck. In the patients with cT1N0M0, the occult metastic rate was 10% (8 out of the 77 T1 patients), so routine SND I-III might not be necessary.
Selective neck dissection of level i-iii remains the elective neck dissection of choice in cT2-4N0 cases. When frozen section sampling is tumor-positive, it does not seem to be necessary to extend routine perioperative frozen section sampling or neck dissection to levels IV and V, because no metastases were found beyond level III. Therefore the indications for routine perioperative frozen section sampling are limited.
CHAPTER 2
reference list
1. Leemans CR, Tiwari R, Nauta JJ, van der Waal, I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71:452- 456.
2. Leemans CR, Tiwari R, Nauta JJ, van der Waal, I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994; 73:187- 190.
3. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982; 7:185-192.
4. Van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol 2000; 33:230-238.
5. Van den Brekel MW, Castelijns JA, Stel HV et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 1991; 180:457-461.
6. Pitman KT, Ferlito A, Devaney KO, Shaha AR, Rinaldo A. Sentinel lymph node biopsy in head and neck cancer. Oral Oncol 2003; 39:343-349.
7. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994; 120:699-702.
8. Crile G. Landmark article Dec 1, 1906: Excision of cancer of the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations. By George Crile. JAMA 1987; 258:3286-3293.
9. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990; 66:109-113.
10. Spiro RH, Morgan GJ, Strong EW, Shah JP. Supraomohyoid neck dissection. Am J Surg 1996; 172:650- 653.
11. Traynor SJ, Cohen JI, Gray J, Andersen PE, Everts EC. Selective neck dissection and the management of the node-positive neck. Am J Surg 1996; 172:654-657.
12. Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 1997; 19:14-19. 13. Crean SJ, Hoffman A, Potts J, Fardy MJ. Reduction of occult metastatic disease by extension of the
AssEssMEnT of PREoPERATIvE ulTRAsonoGRAPHy of THE nECk And ElECTIvE nECk dIssECTIon In PATIEnTs WITH oRAl squAMous CEll CARCInoMA
35
CHAPTER
2.0
18. Van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993; 250:11-17.
19. Van den Brekel MW, Reitsma LC, Quak JJ et al. Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J Neuroradiol 1999; 20:1727-1731.
20. Kowalski LP, Magrin J, Waksman G et al. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch Otolaryngol Head Neck Surg 1993; 119:958-963. 21. Smith GI, O’Brien CJ, Clark J et al. Management of the neck in patients with T1 and T2 cancer in the
mouth. Br J Oral Maxillofac Surg 2004; 42:494-500.
22. Byers RM, Clayman GL, McGill D et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999; 21:499-505.
23. Dias FL, Lima RA, Kligerman J et al. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg 2006; 134:460-465.
24. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group. Am J Surg 1998; 176:422-427.
25. Knegt PP, Keus RB, Roodenburg JL. [The practice guideline ‘Carcinoma of the oral cavity and oropharynx’]. Ned Tijdschr Geneeskd 2006; 150:83-88.
26. Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 2005; 27:739-747. 27. Takes RP, Knegt P, Manni JJ et al. Regional metastasis in head and neck squamous cell carcinoma:
revised value of US with US-guided FNAB. Radiology 1996; 198:819-823.
28. Wensing BM, Vogel WV, Marres HA et al. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 2006; 116:809-813.
29. Heesakkers RA, Futterer JJ, Hovels AM et al. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience. Radiology 2006; 239:481-487. 30. Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ. Superparamagnetic iron oxideenhanced MR
imaging of head and neck lymph nodes. Radiology 2002; 222:239-244.
31. Sigal R, Vogl T, Casselman J et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial. Eur Radiol 2002; 12:1104-1113.
32. Curvo-Semedo L, Diniz M, Migueis J et al. USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer. J Magn Reson Imaging 2006; 24:123-131.